Inogen Announces First Quarter 2024 Financial Results
Inogen, Inc. Home
Latest Events
Jun 5, 2024 • 10:00am PDTInogen 2024 Annual Meeting of Shareholders
Latest Financial Results
Q1 2024
Quarter Ended Mar 31, 2024
$78M
First quarter 2024 revenue of $78.0 million
8.1%
First quarter 2024 revenue grew 8.1% year-over-year
44.1%
First quarter 2024 gross margin of 44.1%
For complete information regarding our financials, see our periodic filings
Annual Reports & Proxy Statements
Inogen 2024 Annual Meeting of Shareholders
Jun 5, 2024 • 10:00am PDT
Sign up for Email Alerts
Give Me AlertsStock Information
Inogen, Inc.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.
View Company Profile2023 Revenue Breakdown
2022 Revenue Breakdown
Products
Inogen Rove 6®
- 6 pulse dose settings
- 4.8 pounds
- Battery life up to 12 hours and 45 minutes
- Technology clinically validated for 24/7 use
- Meets FAA requirements
Inogen One G4®
- 3 flow settings
- 2.8 pounds
- Battery life up to 5 hours
- Meets FAA requirements
- Technology clinically validated for 24/7 use
Inogen At Home®
- 5 liters per minute, continuous flow
- Only 18 pounds
- Extremely quiet
- Energy-efficient
- Only 100W on Flow Setting 2